Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway
Open Access
- 1 June 2015
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 35 (11) , 1992-2006
Abstract
Serum glucocorticoid kinase 1 (SGK1) has been shown to be protective in models of Parkinson's disease, but the details by which it confers benefit is unknown. The current study was designed to investigate the details by which SGK1 confers neuroprotection. To do this we employed a cellular neurodegeneration model to investigate JNK signaling and endoplasmic reticulum (ER) stress induced by 6-hydroxydopamine. SGK1 adenovirus was created and used to over-express SGK1 in SHSY5Y cells and dexamethasone was used to increase endogenous expression of SGK1. Oxidative stress, mitochondrial dysfunction, and cell death were monitored to test the protective effect of SGK1. To investigate the effect of SGK1 over-expression in vivo, SGK1 adenovirus was injected into the striatum of mice treated with1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, and protection of dopaminergic neurons was quantitatively assessed by tyrosine hydroxylase immunohistochemistry. SGK1 over-expression was found to decrease reactive oxygen species generation, alleviate mitochondrial dysfunction, and rescue cell death in vitro and in vivo by inactivating MKK4, JNK, and GSK3β and thereby decreasing ER and oxidative stress. These results suggest therapeutic strategies for activation of SGK1 may have the potential to be neuroprotective by deactivating the JNK and GSK3β pathways.Keywords
This publication has 40 references indexed in Scilit:
- JNK regulates FoxO-dependent autophagy in neuronsGenes & Development, 2011
- JNK Inhibition Protects Dopamine Neurons and Provides Behavioral Improvement in a Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s DiseaseACS Chemical Neuroscience, 2011
- Significance of SGK1 in the regulation of neuronal functionThe Journal of Physiology, 2010
- The physiological impact of the serum and glucocorticoid-inducible kinase SGK1Current Opinion in Nephrology and Hypertension, 2009
- JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degenerationJournal of Neurochemistry, 2008
- A brain-specific SGK1 splice isoform regulates expression of ASIC1 in neuronsProceedings of the National Academy of Sciences, 2008
- Negative regulation of SEK1 signaling by serum‐ and glucocorticoid‐inducible protein kinase 1The EMBO Journal, 2007
- Hsp70 Gene Transfer by Adeno-associated Virus Inhibits MPTP-Induced Nigrostriatal Degeneration in the Mouse Model of Parkinson DiseaseMolecular Therapy, 2005
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993